Levocetirizine (Xyzal®)
| Disease area studied | Abbreviated title | Phase | Study ID | Registry database | Study results | Plain language summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Allergic Rhinitis | Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites | Phase 4 |
A00333
Completed |
NCT00521131 | "Didier. Eur Respir J;2004;24;Suppl 48;124S. 14th ERS (European Respiratory Society) Annual Congress, September 4-8, 2004;Glasgow, UK." | ||
| Allergic Rhinitis | ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life) | Phase 4 |
A00392
Completed |
NCT00160680 2004-003858-26 |
LINK LINK |
Canonica et al. Curr Med Res Opin;2008;24(10);2829-2839. | |
| Allergy | Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children | Phase 2 |
A00315
Completed |
NCT00520754 | Cranswick et al. Int J Clin Pharmacol Ther;2005;43(4);172-177. | ||
| Allergy Rhinitis | Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing SAR Symptoms in Ragweed Sensitive Subjects | Phase 4 |
A00414
Completed |
NCT00295022 |
LINK
|
Day et al. Allerg Asthma Proc;2008;29(3);304-312. | |
| Allergy | Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine | Phase 4 |
A00420
Completed |
NCT00453583 | Ferrer et al. Clin Drug Investig. 2010;30(1);15-34. | ||
| Allergic Rhinitis | Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months | Phase 3 |
A00423
Completed |
NCT00628108 2007-003458-28 |
LINK LINK |
Hampel et al. Allergy Asthma Proc;2010;31(4);290-295. | |
| Allergic Rhinitis | Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin | Phase 3 |
A00426
Completed |
NCT00619801 2015-000205-39 |
LINK LINK |
Hampel et al. Allergy Asthma Proc;2010;31(4);290-295. | |
| Allergic Rhinitis | Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis | Phase 4 |
A00324
Completed |
NCT00542607 | Horak et al. Br J Clin Pharmacol;2005;60(1);24-31. | ||
| Allergy Rhinitis | Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen | Phase 3 |
A00415
Completed |
NCT00315523 | Patel & Patel. Ann Allergy Asthma Immunol;2008;101(3);287-294. | ||
| Urticaria | CUTE (Chronic Urticaria Treatment Evaluation) | Phase 4 |
A00394
Completed |
NCT00264303 2005-000358-65 |
LINK LINK |
Potter et al. Allergy;2009;64(4);596-604. | |
| Allergic Rhinitis | A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis | Phase 4 |
A00430
Completed |
NCT00621959 |
LINK
|
Segall et al. Ann Allergy Asthma Immunol;2010;104(3);259-267. | |
| Allergic Rhinitis | A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis | Phase 4 |
A00431
Completed |
NCT00653224 |
LINK
|
Segall et al. Ann Allergy Asthma Immunol;2010;104(3);259-267. | |
| Allergy | Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM) | Phase 3 |
A00309
Completed |
NCT00152464 |
LINK |
Simons. Ann Allergy Asthma Immunol;2007;99(3);261-266. | |
| Allergic Rhinitis | Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR | Phase 3 |
A00306
Completed |
NCT00521040 | |||
| Urticaria | Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria | Phase 3 |
A00334
Completed |
NCT00525382 | |||
| Allergic Rhinitis | To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis | Phase 3 |
A00348
Completed |
NCT00525278 | |||
| Allergic Rhinitis | Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis | Phase 3 |
A00349
Completed |
NCT00524836 | |||
| Allergic Rhinitis | Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects | Phase 3 |
A00379
Completed |
NCT00544388 | |||
| Allergy | Facial Thermography Study of Levocetirizine Versus Cetirizine | Phase 4 |
A00380
Completed |
NCT00150761 | |||
| Asthma | Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464) | Phase 3 |
A00384
Terminated |
NCT00160563 |
LINK
|
||
| Allergic Rhinitis | Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis | Phase 2 |
A00385
Completed |
NCT00152412 | |||
| Allergic Rhinitis | POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis) | Phase 4 |
A00391
Completed |
NCT00160537 2004-002971-18 |
LINK
|
||
| Allergic Rhinitis | LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis) | Phase 4 |
A00401
Completed |
NCT00160589 2004-002823-42 |
LINK
|
||
| Dermatitis - Eczema | Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema | Phase 3 |
A00410
Completed |
NCT00375713 |
LINK
|
||
| Allergic Rhinitis | Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen | Phase 2 |
A00412
Completed |
NCT00291642 |
LINK
|